The University of Alabama at Birmingham was ranked 42nd out of 303 leading biomedical research institutions nationwide for turning scientific discoveries into real-world healthcare impact, according to the inaugural 2026 Cure Innovation Index.
The ranking places UAB among the top five public institutions in the Southeast, marking it the only public university in the Deep South to reach the top 50.
The index identified UAB as the youngest university to rank in its top tier after evaluating 243 universities and 60 institutes based on research capabilities, entrepreneurial readiness and market translation.
UAB demonstrates its greatest strength in moving innovations to market and preparing researchers for entrepreneurship, according to the ranking report.
“Innovation means more than the thrill of discovery and the benefits of economic impact,” UAB President Ray Watts wrote in a news release.
“At UAB, it means saving and improving more lives. That’s why we view this top-tier Cure Innovation Index ranking as just the beginning, and why we will continue to build our innovation and entrepreneurship momentum.”
The university’s technology transfer and commercialization office, the Bill L. Harbert Institute for Innovation and Entrepreneurship, has supported the launch of more than 20 startups in the past five years, according to the release.
And it said two programs drive this growth: the Blazer Bridge Fund, which provides early-stage funding for intellectual property, and the Blazer App Accelerator, which offers mentorship for software validation.
Kathy Nugent, UAB senior associate vice president and chief biotechnology and innovation officer, said the ranking reflects the ingenuity of the university’s innovators and the efficiency of the technology transfer team.
She noted that these efforts help translate discoveries into solutions that benefit patients beyond the campus.
Stories by Heather Gann on AL.com